Skip to main content

Animations

MJFF Publications

5261 - 5270 of 6420 Results
Title
Year
  • Year
  • 2016
  • 2024
  • 2024
  • 2010
  • 2022
  • 2025
  • 2022
  • 2021
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.6b00217
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddae018
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49016-3
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23442
    Citation Count: 167
  • Summary Details
    OPEN
    Title: Putting participants and study partners FIRST when clinical trials end early
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12732
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Early α-synuclein aggregation decreases corticostriatal glutamate drive and synapse density
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106918
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02770-7
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02285-4
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac176
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Performance of machine learning algorithms for dementia assessment: impacts of language tasks, recording media, and modalities
    Journal Name: BMC Medical Informatics and Decision Making
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12911-023-02122-6
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.